Oncology Surgery Faculty
Douglas S. Tyler, MD
John Woods Harris Distinguished Chair in Surgery
Professor and Chairman, Department of Surgery
Medical School: Dartmouth Medical School, Hanover, New Hampshire
Residency Program: Duke University Medical Center, Durham, North Carolina
Fellowship: Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Awards/Honors: 1998, 2007-David C. Sabiston, Jr. Teaching Award (for excellence in resident education); 1998-2017-selected for inclusion in Castle Connolly Medical Ltd. The Best Doctors in America; 1998, 2003-American Board of Surgery Associate Examiner (for oral certifying examination); 1999-Duke University Davison Society's Davison Teaching Award (for excellence in medical student education); 2002-recipient of The American College of Surgeons Traveling Fellowship to Australia and New Zealand; 2008-Duke University Health System Strength, Hope, and Caring Award (for leadership in patient care and safety at Duke University Hospital); 2010-2016-Director, American Board of Surgery (nominated and elected as Society of Surgical Oncology representative); 2011-Durham VA Medical Center "Partners in Care" Nursing Service Excellence Award; 2013-Duke Surgery Excellence in Simulation Teaching Award (for providing exemplary service in skills training to surgical residents in the surgical education and activities lab; 2014-Durham VA Medical Center Director's Commendation (in recognition of over 20 years of exemplary service within the surgical service and contributions to the VA mission)
Editorial Boards: Annals of Surgical Oncology, Surgery, World Journal of Gastrointestinal Surgery
NIH Study Sections: NCI-Developmental Therapeutics (DT): Telephone reviewer 10/2005; CTEP/NCI-External Reviewer: Phase 3 clinical trial concepts 05/2008; NCI-Clinical Studies P01: Special Emphasis Panel Review 06/2010, 06/2011; Veterans Affairs: OncE Merit Review Panel: 2015-2018
Clinical interests: Dr. Tyler's clinical practice focuses on GI cancers, melanoma, and sarcoma. He has pioneered neoadjuvant approaches using chemotherapy and/or radiation to tumors of the stomach and pancreas as well as the application of minimally invasive surgery to tumors of the GI tract. He is an expert in the management of regionally advanced and in-transit melanoma and oversees novel clinical trials to manage this form of disease. Dr. Tyler also has extensive experience managing retroperitoneal and abdominal wall sarcomas.
Research interests: Dr. Tyler's research interest is in novel strategies to treat regionally advanced melanoma. The main focus currently is on how regional treatments can augment systemic immunotherapy strategies. His work spans preclinical animal models, through phase I and II regional therapy clinical trials associated with correlative science studies.
301 University Boulevard
Galveston, Texas 77555-0527
Telephone: (409) 772-1285